It has been shown recently that suppression of ERβ in the ERα-negative MDA-MB-231 breast cancer cells decreased the EMT inducer miR-10b and elevated the expression of the tumor suppressor miR-145, thereby inhibiting EMT and provoking major changes in certain matrix components [72] (Figure 1). Here, ESR2 is linked to breast carcinoma.